490 related articles for article (PubMed ID: 9539597)
1. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
[TBL] [Abstract][Full Text] [Related]
2. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study.
Van Heerden PV; Blythe D; Webb SA
Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667
[TBL] [Abstract][Full Text] [Related]
3. Inhaled nitric oxide for the adult respiratory distress syndrome.
Rossaint R; Falke KJ; López F; Slama K; Pison U; Zapol WM
N Engl J Med; 1993 Feb; 328(6):399-405. PubMed ID: 8357359
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema.
Zwissler B; Welte M; Habler O; Kleen M; Messmer K
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):634-40. PubMed ID: 8664452
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
[TBL] [Abstract][Full Text] [Related]
7. Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome.
Nakagawa TA; Morris A; Gomez RJ; Johnston SJ; Sharkey PT; Zaritsky AL
J Pediatr; 1997 Jul; 131(1 Pt 1):63-9. PubMed ID: 9255193
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury.
Jacobs BR; Brilli RJ; Ballard ET; Passerini DJ; Smith DJ
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1536-42. PubMed ID: 9817705
[TBL] [Abstract][Full Text] [Related]
9. Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
Stanek B; Sturm B; Frey B; Hülsmann M; Bojic A; Berger R; Rödler S; Locker G; Grimm M; Laufer G; Pacher R
J Heart Lung Transplant; 1999 Apr; 18(4):358-66. PubMed ID: 10226901
[TBL] [Abstract][Full Text] [Related]
10. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome.
Putensen C; Hörmann C; Kleinsasser A; Putensen-Himmer G
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1743-7. PubMed ID: 9620900
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.
Walmrath D; Schneider T; Schermuly R; Olschewski H; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1996 Mar; 153(3):991-6. PubMed ID: 8630585
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome.
Kunimoto F; Arai K; Isa Y; Koyano T; Kadoi Y; Saito S; Goto F
Anesth Analg; 1997 Sep; 85(3):507-13. PubMed ID: 9296401
[TBL] [Abstract][Full Text] [Related]
16. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
De Wet CJ; Affleck DG; Jacobsohn E; Avidan MS; Tymkew H; Hill LL; Zanaboni PB; Moazami N; Smith JR
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1058-67. PubMed ID: 15052203
[TBL] [Abstract][Full Text] [Related]
17. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
[TBL] [Abstract][Full Text] [Related]
18. Cardiac surgery and inhaled nitric oxide: indication and follow-up (2-4 years).
Yahagi N; Kumon K; Tanigami H; Watanabe Y; Haruna M; Hayashi H; Imanaka H; Takeuchi M; Takamoto S
Artif Organs; 1998 Oct; 22(10):886-91. PubMed ID: 9790088
[TBL] [Abstract][Full Text] [Related]
19. Vasodilators in mechanical ventilation.
Zimmerman JL; Hanania NA
Crit Care Clin; 1998 Oct; 14(4):611-27. PubMed ID: 9891630
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide in pediatric intensive care.
Zobel G; Rödl S; Gamillscheg A; Urlesberger B; Trop M; Grubbauer HM
Acta Anaesthesiol Scand Suppl; 1996; 109():92-6. PubMed ID: 8901961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
